Aristotle Atlantic Partners’s Organon & Co OGN Stock Holding History

Aristotle Atlantic Partners’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-43,431	Closed	-$626K	–	96
2023 Q4	$626K	Hold	43,431	–	–	0.02%	86
2023 Q3	$754K	Hold	43,431	–	–	0.03%	86
2023 Q2	$904K	Hold	43,431	–	–	0.03%	84
2023 Q1	$1.02M	Hold	43,431	–	–	0.05%	79
2022 Q4	$1.21M	Hold	43,431	–	–	0.07%	78
2022 Q3	$1.02M	Hold	43,431	–	–	0.06%	77
2022 Q2	$1.47M	Sell	43,431 -500	-1%	-$17.5K	0.11%	77
2022 Q1	$1.53M	Hold	43,931	–	–	0.1%	78
2021 Q4	$1.34M	Hold	43,931	–	–	0.08%	80
2021 Q3	$1.44M	Sell	43,931 -13,890	-24%	-$444K	0.1%	77
2021 Q2	$1.75M	Buy	+57,821	New	+$1.9M	0.12%	79

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Aristotle Atlantic Partners's OGN Position: Q1 2024 in Review

Aristotle Atlantic Partners sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 43,431 shares — an estimated $626K sold.

Aristotle Atlantic Partners first reported a position in OGN in Q2 2021 and held it in 11 quarters. The position peaked at $1.75M in Q2 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

Aristotle Atlantic Partners reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
Aristotle Atlantic Partners sold 43,431 Organon & Co shares in Q1 2024, an estimated $626K.
Aristotle Atlantic Partners first reported a position in Organon & Co in Q2 2021 and held it in 11 quarters.
Aristotle Atlantic Partners's Organon & Co position peaked at $1.75M in Q2 2021.
719 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Aristotle Atlantic Partners's 13F filing for Q1 2024, filed 15 May 2024.